Skip to content
POM-V Prescription Required Companion Animal

Vetmedin 0.75 mg/ml Solution for Injection for Dogs

Active ingredient: Pimobendan

Form

Injection

Species

Dogs

Manufacturer

Boehringer Ingelheim Vetmedica GmbH

VMD MA No.

04491/3032

What it's used for

For the treatment of dilated cardiomyopathy in the preclinical stage (asymptomatic with an increase in left ventricular end-systolic and end-diastolic diam...

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Pimobendan

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Vetmedin 0.75 mg/ml Solution for Injection for Dogs — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

For the treatment of dilated cardiomyopathy in the preclinical stage (asymptomatic
with an increase in left ventricular end-systolic and end-diastolic diameter) in
Doberman Pinschers following echocardiographic diagnosis of cardiac disease.
To ensure a correct dosage, body weight should be determined as accurately as
possible.
The recommended dosage is 0.15 mg pimobendan/kg body weight (i.e. 2 ml/10 kg
body weight).
A 5 ml and a 10 ml vial can treat up to a 25 kg and 50 kg body weight dog,
respectively.
Each vial is for single use only.
Vetmedin chewable tablets or Vetmedin capsules for dogs may be used for
continuation of treatment at the recommended dosage, to be started 12 hours after
administration of the injection.
Do not use in cases of hypersensitivity to the active substance or to any of the
excipients.
Do not use in cases of hypertrophic cardiomyopathies or clinical conditions where an
augmentation of cardiac output is not possible for functional or anatomical reasons
(e.g. aortic stenosis).
Dogs:
Rare
(1 to 10 animals / 10,000
animals treated):
- Vomiting, diarrhoea
- Anorexia
, lethargy
- Increased heart rate
1
Transient
Due to a moderate chronotropic effect
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or its local representative or the national
competent authority via the national reporting system. See the package leaflet for
respective contact details.
None.

Special precautions for safe use in the target species:
In case of accidental subcutaneous injection temporary swelling and mild to slight
resorptive inflammatory reactions can occur at or below the injection site.
For single administration only.
The veterinary medicinal product should be used for the initiation of treatment of
congestive heart failure in dogs, following a risk:benefit assessment by the
responsible veterinarian, taking into account the overall health status of the dog.
Before treatment, diagnosis should be made by the means of a comprehensive
physical and cardiac examination which should include echocardiography or
radiography where appropriate.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
In case of accidental self-injection, seek medical advice immediately and show the
package leaflet or the label to the physician.
Wash hands after use.
Special precautions for the protection of the environment:
Not applicable.
In pharmacological studies no interaction between the cardiac glycoside ouabain and
pimobendan was detected. The pimobendan-induced increase in contractility of the
heart is attenuated in the presence of the calcium antagonist verapamil and the ß-
antagonist propranolol.
This veterinary medicinal product does not require any special storage conditions.
This veterinary medicinal product does not contain an antimicrobial preservative.
This veterinary medicinal product is intended for single use only.
Any veterinary medicinal product remaining in the bottle after withdrawal of the
required dose should be discarded.
Not applicable.
4.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.